Inc. has the following information for $2022$ and $2023$:

Revenues $($in thousands$)2022=$ $$40,0002023=$ $$46,000$

COGS $($in thousands$)2022=32,0002023=36,200$

Selling and Administrative expenses other than interest $($in thousands$)2022=4,2002023=5,100$

Loss on discounted operation $$ net of tax $($in thousands$)2023=700$

Tax rate $2022=25\%2023=20\%$

$$ In both $2022$ and $2023$ Chloe incurred $9\mathrm{.}5\%$ interest expense on $$2,000,000$ of debt which had been issued at par in $2018.$

$$ As of $1/1/22$ there were $3,000,000$ shares of common stock outstanding.

$$ There were also $20,000$ shares of $$100$ par value,$7\%,$ cumulative preferred stock outstanding at $1/1/22.$

$$ There are no preferred dividends in arrears and there are no potentially dilutive securities$.$

$$ On $5/1/22$ Chloe sold an additional $500,000$ shares of common stock at $$32$ per share.

$$ On $8/1/22$ Chloe issued a $25\%$ stock dividend.

$$ On $10/1/23$ Chloe sold another $900,000$ shares of common stock at $$33$ per share.

Prepare, in good form, comparative income statements for $2022$ and $2023($i$.$e$.,$ the two$-$year

Comparative income statements for the years ended $12/31/23)$ for Chloe, Inc. with appropriate EPS information rounded to the nearest tenth of a cent.